Gamma Investing LLC Puma Biotechnology, Inc. Transaction History
Gamma Investing LLC
- $1.99 Trillion
- Q4 2025
A detailed history of Gamma Investing LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 139 shares of PBYI stock, worth $688. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139
Previous 78
78.21%
Holding current value
$688
Previous $414,000
99.76%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PBYI
# of Institutions
135Shares Held
35.2MCall Options Held
264KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.4 Million11.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$10.6 Million0.02% of portfolio
-
Acadian Asset Management LLC Boston, MA2.05MShares$10.2 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $226M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...